BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 19451796)

  • 1. High ongoing burden of cryptococcal disease in Africa despite antiretroviral roll out.
    Jarvis JN; Boulle A; Loyse A; Bicanic T; Rebe K; Williams A; Harrison TS; Meintjes G
    AIDS; 2009 Jun; 23(9):1182-3. PubMed ID: 19451796
    [No Abstract]   [Full Text] [Related]  

  • 2. Cryptococcal antigenemia is associated with meningitis or death in HIV-infected adults with CD4 100-200 cells/mm
    Wykowski J; Galagan SR; Govere S; Wallis CL; Moosa MY; Celum C; Drain PK
    BMC Infect Dis; 2020 Jan; 20(1):61. PubMed ID: 31959112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is HIV-associated tuberculosis a risk factor for the development of cryptococcal disease?
    Jarvis JN; Harrison TS; Corbett EL; Wood R; Lawn SD
    AIDS; 2010 Feb; 24(4):612-4. PubMed ID: 19952711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreasing incidence of cryptococcal meningitis in West Africa in the era of highly active antiretroviral therapy.
    Bamba S; Lortholary O; Sawadogo A; Millogo A; Guiguemdé RT; Bretagne S
    AIDS; 2012 May; 26(8):1039-41. PubMed ID: 22552479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors influencing cerebrospinal fluid and plasma HIV-1 RNA detection rate in patients with and without opportunistic neurological disease during the HAART era.
    Christo PP; Greco DB; Aleixo AW; Livramento JA
    BMC Infect Dis; 2007 Dec; 7():147. PubMed ID: 18096083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cryptococcal meningitis in HIV-infected patients: a longitudinal study in Cambodia.
    Espié E; Pinoges L; Balkan S; Chanchhaya N; Molfino L; Narom P; Pujades-Rodríguez M
    Trop Med Int Health; 2010 Nov; 15(11):1375-81. PubMed ID: 20868415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cryptococcal meningitis in a tertiary hospital in Pretoria, mortality and risk factors - A retrospective cohort study.
    Hiesgen J; Schutte C; Olorunju S; Retief J
    Int J STD AIDS; 2017 Apr; 28(5):480-485. PubMed ID: 27255493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of adult meningitis during antiretroviral therapy scale-up in southern Africa: Results from the Botswana national meningitis survey.
    Tenforde MW; Mokomane M; Leeme T; Tlhako N; Tsholo K; Ramodimoosi C; Dube B; Mokobela KO; Tawanana E; Chebani T; Pilatwe T; Hurt WJ; Mitchell HK; Molefi M; Mullan PC; Guthrie BL; Farquhar C; Steenhoff AP; Mine M; Jarvis JN
    J Infect; 2019 Sep; 79(3):212-219. PubMed ID: 31255634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of Cryptococcal Antigen Screening and Evolution of Asymptomatic Cryptococcal Antigenemia among HIV-Infected Women Starting Antiretroviral Therapy in Thailand.
    Kwan CK; Leelawiwat W; Intalapaporn P; Anekthananon T; Raengsakulrach B; Peters PJ; McNicholl JM; Park BJ; McConnell MS; Weidle PJ
    J Int Assoc Provid AIDS Care; 2014; 13(5):434-7. PubMed ID: 24003059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of cryptococcal meningitis in antiretroviral naïve and experienced patients in South Africa.
    Jarvis JN; Meintjes G; Harrison TS
    J Infect; 2010 Jun; 60(6):496-8. PubMed ID: 20307571
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of screening and treatment of cryptococcal antigenaemia among HIV-infected persons in Soweto, South Africa.
    Govender NP; Roy M; Mendes JF; Zulu TG; Chiller TM; Karstaedt AS
    HIV Med; 2015 Sep; 16(8):468-76. PubMed ID: 25689352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Causes of death in patients with HIV infection in two Tunisian medical centers].
    Chelli J; Bellazreg F; Aouem A; Hattab Z; Mesmia H; Lasfar NB; Hachfi W; Masmoudi T; Chakroun M; Letaief A
    Pan Afr Med J; 2016; 25():105. PubMed ID: 28292068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asymptomatic cryptococcal antigen prevalence detected by lateral flow assay in hospitalised HIV-infected patients in São Paulo, Brazil.
    Vidal JE; Toniolo C; Paulino A; Colombo A; Dos Anjos Martins M; da Silva Meira C; Pereira-Chioccola VL; Figueiredo-Mello C; Barros T; Duarte J; Fonseca F; Alves Cunha M; Mendes C; Ribero T; Dos Santos Lazera M; Rajasingham R; Boulware DR
    Trop Med Int Health; 2016 Dec; 21(12):1539-1544. PubMed ID: 27699970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The burden of HIV-associated cryptococcal disease.
    Harrison TS
    AIDS; 2009 Feb; 23(4):531-2. PubMed ID: 19240459
    [No Abstract]   [Full Text] [Related]  

  • 15. Frequency of cryptococcal meningitis in HIV-1 infected patients in north central Nigeria.
    Gomerep SS; Idoko JA; Ladep NG; Ugoya SO; Obaseki D; Agbaji OA; Agaba P; Akanbi MO; Badung BP; Otitoloju O
    Niger J Med; 2010; 19(4):395-9. PubMed ID: 21526627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis.
    Rajasingham R; Smith RM; Park BJ; Jarvis JN; Govender NP; Chiller TM; Denning DW; Loyse A; Boulware DR
    Lancet Infect Dis; 2017 Aug; 17(8):873-881. PubMed ID: 28483415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profile of central nervous system disease in HIV/AIDS patients with special reference to cryptococcal infections.
    Wadhwa A; Kaur R; Bhalla P
    Neurologist; 2008 Jul; 14(4):247-51. PubMed ID: 18617851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and factors associated with cryptococcal antigenemia among severely immunosuppressed HIV-infected adults in Uganda: a cross-sectional study.
    Oyella J; Meya D; Bajunirwe F; Kamya MR
    J Int AIDS Soc; 2012 Mar; 15(1):15. PubMed ID: 22417404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence, correlates, and outcomes of cryptococcal antigen positivity among patients with AIDS, United States, 1986-2012.
    McKenney J; Bauman S; Neary B; Detels R; French A; Margolick J; Doherty B; Klausner JD
    Clin Infect Dis; 2015 Mar; 60(6):959-65. PubMed ID: 25422390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discontinuation of maintenance therapy for cryptococcal meningitis in patients with AIDS treated with highly active antiretroviral therapy: an international observational study.
    Mussini C; Pezzotti P; Miró JM; Martinez E; de Quiros JC; Cinque P; Borghi V; Bedini A; Domingo P; Cahn P; Bossi P; de Luca A; d'Arminio Monforte A; Nelson M; Nwokolo N; Helou S; Negroni R; Jacchetti G; Antinori S; Lazzarin A; Cossarizza A; Esposito R; Antinori A; Aberg JA;
    Clin Infect Dis; 2004 Feb; 38(4):565-71. PubMed ID: 14765351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.